THOMAS SMALLWOOD: Open Payments
NPI 1386644938 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 75 payments from 12 companies in 2025. Trend: 2023 $961 · 2024 $825 · 2025 $1,446
Food & beverage: $1,404Education: $43
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $318 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $269 |
| Vanda Pharmaceuticals Inc. | 7 | $187 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| Novo Nordisk Inc | 6 | $114 |
| Kowa Pharmaceuticals America, Inc. | 5 | $72 |
| Abbott Laboratories | 4 | $71 |
| Lilly USA, LLC | 3 | $52 |
| Mannkind Corporation | 1 | $43 |
Products named: AUSTEDO XR, CAPLYTA, FANAPT, AIRSUPRA, INGREZZA, Ozempic, ZORYVE, FREESTYLE LIBRE 3.
Industry payments across OH — which companies pay providers there.
